{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:03:43Z","timestamp":1770519823282,"version":"3.49.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA014089"],"award-info":[{"award-number":["P30CA014089"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Gloria Borges Wunderglo Project"},{"DOI":"10.13039\/100006508","name":"Dhont Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006508","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Daniel Butler Research Fundation"},{"name":"Call to Cure Research Fundation"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["S2606"],"award-info":[{"award-number":["S2606"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Takashi Tsuruo Memorial Fundation"},{"name":"Werner and Hedy Berger-Janser Foundation","award":["KLS-3334-02- 2014"],"award-info":[{"award-number":["KLS-3334-02- 2014"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0239439","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T17:29:20Z","timestamp":1600968560000},"page":"e0239439","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3948-5044","authenticated-orcid":true,"given":"Yuji","family":"Miyamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Schirripa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-2893","authenticated-orcid":true,"given":"Mitsukuni","family":"Suenaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin D.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Matsusaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotios","family":"Loupakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Pietrantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Borelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Cremolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz-Josef","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"pone.0239439.ref001","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ijc.25864","article-title":"Regorafenib (BAY 73\u20134506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity","volume":"129","author":"SM Wilhelm","year":"2011","journal-title":"Int J cancer"},{"key":"pone.0239439.ref002","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","article-title":"Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): An international, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"381","author":"A Grothey","year":"2013","journal-title":"Lancet"},{"key":"pone.0239439.ref003","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1470-2045(15)70156-7","article-title":"Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"16","author":"J Li","year":"2015","journal-title":"Lancet Oncol"},{"key":"pone.0239439.ref004","unstructured":"Network NCC. National Comprehensive Cancer Network (NCCN). Guidel Version 1 2016 Colon Cancer. 2016. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0001308\/"},{"key":"pone.0239439.ref005","first-page":"mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","author":"E Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"pone.0239439.ref006","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9187","article-title":"Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer","volume":"7","author":"M Suenaga","year":"2016","journal-title":"Oncotarget"},{"key":"pone.0239439.ref007","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1470-2045(15)00138-2","article-title":"Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial","volume":"16","author":"J Tabernero","year":"2015","journal-title":"Lancet Oncol"},{"key":"pone.0239439.ref008","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"K Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"pone.0239439.ref009","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1007\/s00520-012-1460-5","article-title":"Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation","volume":"20","author":"S Morishita","year":"2012","journal-title":"Support Care Cancer"},{"key":"pone.0239439.ref010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0959-8049(97)10090-9","article-title":"Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?","volume":"34","author":"HJ Andreyev","year":"1998","journal-title":"Eur J Cancer"},{"key":"pone.0239439.ref011","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","article-title":"Myostatin\/activin pathway antagonism: Molecular basis and therapeutic potential","volume":"45","author":"HQ Han","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"pone.0239439.ref012","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of activin A and myostatin in human cancer cachexia","volume":"100","author":"A Loumaye","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0239439.ref013","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1158\/1078-0432.CCR-16-0495","article-title":"Molecular Pathways: Cachexia Signaling\u2014A Targeted Approach to Cancer Treatment","volume":"22","author":"Y Miyamoto","year":"2016","journal-title":"Clin cancer Res"},{"key":"pone.0239439.ref014","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3892\/or.2013.2761","article-title":"Significance of INHBA expression in human colorectal cancer","volume":"30","author":"M Okano","year":"2013","journal-title":"Oncol Rep"},{"key":"pone.0239439.ref015","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1158\/0008-5472.CAN-14-0057","article-title":"Myostatin gene inactivation prevents skeletal muscle wasting in cancer","volume":"74","author":"YS Gallot","year":"2014","journal-title":"Cancer Res"},{"key":"pone.0239439.ref016","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1210\/en.2004-0213","article-title":"Crucial role of activin a in tubulogenesis of endothelial cells induced by vascular endothelial growth factor","volume":"145","author":"K Maeshima","year":"2004","journal-title":"Endocrinology"},{"key":"pone.0239439.ref017","first-page":"4596","article-title":"The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A","volume":"60","author":"S Breit","year":"2000","journal-title":"Cancer Res"},{"key":"pone.0239439.ref018","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.3590","article-title":"Genetic variations associated with cancer cachexia pathways to predict survival in metastatic colorectal cancer (mCRC): Results from FIRE-3 and TRIBE","volume":"34","author":"Y Miyamoto","year":"2016","journal-title":"J Clin Oncol"},{"key":"pone.0239439.ref019","doi-asserted-by":"crossref","first-page":"e0129742","DOI":"10.1371\/journal.pone.0129742","article-title":"Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer","volume":"10","author":"Y Miyamoto","year":"2015","journal-title":"PLoS One"},{"key":"pone.0239439.ref020","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ncponc0252","article-title":"REporting recommendations for tumor MARKer prognostic studies (REMARK)","volume":"2","author":"LM McShane","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"pone.0239439.ref021","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/153537020222700201","article-title":"Regulation of cell proliferation, apoptosis, and carcinogenesis by activin","volume":"227","author":"YG Chen","year":"2002","journal-title":"Exp Biol Med"},{"key":"pone.0239439.ref022","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/153537020623100507","article-title":"Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis","volume":"231","author":"Y-G Chen","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"pone.0239439.ref023","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","article-title":"Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival","volume":"162","author":"AJ Johnston","year":"2015","journal-title":"Cell"},{"key":"pone.0239439.ref024","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gut.49.3.409","article-title":"Overexpression of activin A in stage IV colorectal cancer","volume":"49","author":"S Wildi","year":"2001","journal-title":"Gut"},{"key":"pone.0239439.ref025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11357-010-9202-4","article-title":"The relationship between fertility and lifespan in humans","volume":"33","author":"M Kuningas","year":"2011","journal-title":"Age (Omaha)"},{"key":"pone.0239439.ref026","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2004.03.011","article-title":"Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells","volume":"126","author":"K Wagner","year":"2004","journal-title":"Gastroenterology"},{"key":"pone.0239439.ref027","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1158\/0008-5472.CAN-04-2828","article-title":"Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms","volume":"65","author":"E Panopoulou","year":"2005","journal-title":"Cancer Res"},{"key":"pone.0239439.ref028","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.canlet.2014.10.037","article-title":"Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer","volume":"356","author":"Y Togashi","year":"2015","journal-title":"Cancer Lett"},{"key":"pone.0239439.ref029","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.V96.1.34","article-title":"Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression","volume":"96","author":"R Salcedo","year":"2000","journal-title":"Blood"},{"key":"pone.0239439.ref030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F","article-title":"Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1","volume":"82","author":"V Goede","year":"1999","journal-title":"Int J cancer"},{"key":"pone.0239439.ref031","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.4049\/jimmunol.1302821","article-title":"CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2\/CCR2-dependent gene expression profile","volume":"192","author":"E Sierra-Filardi","year":"2014","journal-title":"J Immunol"},{"key":"pone.0239439.ref032","first-page":"1952","article-title":"A novel single-nucleotide polymorphism in the 3\u2019-untranslated region of the human dihydrofolate reductase gene with enhanced expression","volume":"7","author":"Y Goto","year":"2001","journal-title":"Clin cancer Res an Off J Am Assoc Cancer Res"},{"key":"pone.0239439.ref033","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1479-7364-4-5-289","article-title":"Characterisation of a functional intronic polymorphism in the human growth hormone (GH1) gene","volume":"4","author":"DS Millar","year":"2010","journal-title":"Hum Genomics"},{"key":"pone.0239439.ref034","first-page":"207","article-title":"Granulosa cells as hormone targets: the role of biologically active follicle-stimulating hormone in reproduction","volume":"45","author":"AJ Hsueh","year":"1989","journal-title":"Recent Prog Horm Res"},{"key":"pone.0239439.ref035","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/edrv.22.6.0450","article-title":"Activins and inhibins in endocrine and other tumors","volume":"22","author":"GP Risbridger","year":"2001","journal-title":"Endocr Rev"},{"key":"pone.0239439.ref036","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mce.2011.07.033","article-title":"Activin and inhibin, estrogens and NFkappaB, play roles in ovarian tumourigenesis is there crosstalk?","volume":"359","author":"AE Drummond","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"pone.0239439.ref037","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/1471-2407-9-320","article-title":"Differential expression of follistatin and FLRG in human breast proliferative disorders","volume":"9","author":"E Bloise","year":"2009","journal-title":"BMC Cancer"},{"key":"pone.0239439.ref038","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1677\/ERC-07-0054","article-title":"Activin and estrogen crosstalk regulates transcription in human breast cancer cells","volume":"14","author":"JE Burdette","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"pone.0239439.ref039","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1210\/en.2006-1083","article-title":"Neonatal exposure to estrogens suppresses activin expression and signaling in the mouse ovary","volume":"148","author":"JL Kipp","year":"2007","journal-title":"Endocrinology"},{"key":"pone.0239439.ref040","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1414325","article-title":"Randomized trial of TAS-102 for refractory metastatic colorectal cancer","volume":"372","author":"RJ Mayer","year":"2015","journal-title":"N Engl J Med"},{"key":"pone.0239439.ref041","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/17512433.2016.1133285","article-title":"A novel antimetabolite: TAS-102 for metastatic colorectal cancer","volume":"9","author":"Y Miyamoto","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"pone.0239439.ref042","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1634\/theoncologist.2017-0275","article-title":"Propensity Score Analysis of Regorafenib Versus Trifluridine\/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study","volume":"23","author":"T Moriwaki","year":"2018","journal-title":"Oncologist"},{"key":"pone.0239439.ref043","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clcc.2017.10.016","article-title":"A Comparison of Regorafenib and TAS-102 for Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis","volume":"17","author":"ABK Abrahao","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"pone.0239439.ref044","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000435783","article-title":"Food Intolerance: Associations with the rs12212067 Polymorphism of FOXO3 in Crohn\u2019s Disease Patients in New Zealand","volume":"8","author":"G Marlow","year":"2015","journal-title":"J Nutrigenet Nutrigenomics"},{"key":"pone.0239439.ref045","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/art.39760","article-title":"Association Between Genetic Variation in FOXO3 and Reductions in Inflammation and Disease Activity in Inflammatory Polyarthritis","volume":"68","author":"S Viatte","year":"2016","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"pone.0239439.ref046","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature11428","article-title":"A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses","volume":"490","author":"V Litvak","year":"2012","journal-title":"Nature"},{"key":"pone.0239439.ref047","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ni.1729","article-title":"Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells","volume":"10","author":"AS Dejean","year":"2009","journal-title":"Nat Immunol"},{"key":"pone.0239439.ref048","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2013.08.034","article-title":"Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway","volume":"155","author":"JC Lee","year":"2013","journal-title":"Cell"},{"key":"pone.0239439.ref049","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00262-007-0358-4","article-title":"Ethnic differences in cytokine gene polymorphisms: Potential implications for cancer development","volume":"57","author":"J Zabaleta","year":"2008","journal-title":"Cancer Immunol Immunother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T17:30:20Z","timestamp":1600968620000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239439"}},"subtitle":[],"editor":[{"given":"Jason Chia-Hsun","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0239439","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]}}}